AstraZeneca to Partner with Oracle to Improve AI-Driven Clinical Trials and Patient Care
ORCL Oracle Corp
$131.14 +1.20%
View chart & analysis → - 1AstraZeneca (AZN) has entered a partnership with Oracle (ORCL) to improve clinical research and medical procedures using AI and cloud technology
- 2Priority areas for exploration include clinical trial patient recruitment, early disease diagnosis, and drug safety monitoring, with the first project being an Abu Dhabi hypertension program
- 3Contract amounts and expansion schedules remain undisclosed, and whether clinical costs will be reduced or patient outcomes improved has not been confirmed
So what's the key point?
AstraZeneca and Oracle are working together to find ways to improve clinical trials and medical care using artificial intelligence and cloud technology. The contract amount was not disclosed, and the actual effectiveness has not yet been confirmed.
Source The Wall Street Journal +3 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.